Cameroon vs Syrian Arab Republic: Deaths from Parkinson's disease
Cameroon
409.7 deaths
in 2021
Syrian Arab Republic
426.41 deaths
in 2021
Cameroon rank
73rd
Syrian Arab Republic rank
70th
Deaths from Parkinson's disease over time
- Cameroon
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 426.41 deaths against 409.7 deaths in Cameroon, a difference of 16.71 deaths.
The two have swapped places 6 times across 22 shared years of data; in 2000 it was Syrian Arab Republic ahead.
Cameroon ranks 73rd and Syrian Arab Republic ranks 70th of 194 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Syrian Arab Republic in 2.
Head to head by decade
| Decade | Cameroon | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 290.37 deaths | 286.65 deaths | 3.71 deaths | Cameroon |
| 2010s | 379.5 deaths | 388.91 deaths | 9.41 deaths | Syrian Arab Republic |
| 2020s | 425.56 deaths | 428.74 deaths | 3.18 deaths | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Cameroon or Syrian Arab Republic?
- Syrian Arab Republic, at 426.41 deaths against 409.7 deaths in Cameroon as of 2021.
- What is the difference in deaths from parkinson's disease between Cameroon and Syrian Arab Republic?
- 16.71 deaths, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Cameroon and Syrian Arab Republic?
- 22 years are reported by both, from 2000 to 2021.
- How do Cameroon and Syrian Arab Republic rank globally for deaths from parkinson's disease?
- Cameroon ranks 73rd and Syrian Arab Republic ranks 70th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.